Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Belbuca Revenue: $53.2 million, up 17% year-over-year. Xtampza ER Revenue: $49.5 million, up 24% year-over-year. Nucynta Franchise Revenue: $45.1 million, down 5% year-over-year. Jornay PM Revenue: $8 million for less than one month of sales. Adjusted EBITDA: $105.1 million, up 18% year-over-year. GAAP Net Income: $9.3 million, down 55% year-over-year. Non-GAAP Adjusted Earnings Per Share: $1.61, up 20% year-over-year. Cash, Cash Equivalents, and Marketable Securities: $120 million as of September 30, 2024. Warning! GuruFocus has detected 4 Warning Sign with COLL. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Collegium Pharmaceutical Inc ( NASDAQ:COLL ) reported a record financial performance in the third quarter of 2024, with total net product revenues reaching $159.3 million, up 17% year-over-year. The acquisition of Ironshore Therapeutics and its commercial product, Jornay
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest [Yahoo! Finance]Yahoo! Finance
- Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Collegium to Participate in Upcoming Investor ConferencesGlobeNewswire
- Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
- Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? [Yahoo! Finance]Yahoo! Finance
COLL
Earnings
- 11/7/24 - Beat
COLL
Sec Filings
- 11/14/24 - Form 3
- 11/14/24 - Form 4
- 11/14/24 - Form 8-K/A
- COLL's page on the SEC website